tirzepatide pens Mounjaro (Tirzepatide) Injection 12.5 mg/0.5 mL Prefilled Syringes (4-Pack) **Refrigeration Required (RX) Mounjaro (tirzepatide) for the Treatment

DUPIXENT should not be used to treat acute symptoms or acute exacerbations of asthma or COPD

Helps patients begin GLP-1 therapy with a lower introductory dose

10.1248/cpb.37.3409 54 KumagaiA.FukushimaJ.TakikawaH.FukudaT.FukusatoT

Haber SL, Awwad O, Phillips A, et al

Other Ingredients: Cellulose, Stearic Acid (Vegetable Source), Magnesium Stearate, Silica, Vegetable Coating No Sugar, No Starch, No Artificial Colors, No Artificial Flavors, No Preservatives, Sodium Free, No Wheat, No Gluten, No Corn, No Soy, No Dairy, Yeast Free

PA requests for non-preferred cytokine and CAM antagonist drugs used to treat PMR may be submitted on the Portal, by fax, or by mail (but not using the STAT-PA system)